What is he best known for?
The fields of study he is best known for:
David Alland mainly investigates Mycobacterium tuberculosis, Genetics, Tuberculosis, Drug resistance and GeneXpert MTB/RIF.
David Alland works in the field of Mycobacterium tuberculosis, focusing on rpoB in particular.
His Tuberculosis research incorporates elements of Internal medicine and Restriction fragment length polymorphism.
His Drug resistance course of study focuses on Rifampicin and Virology.
His GeneXpert MTB/RIF research is multidisciplinary, incorporating elements of Multiple drug resistance, Tuberculosis diagnosis, Antibacterial agent and Clinical trial.
David Alland works mostly in the field of Microbiology, limiting it down to concerns involving Nucleic acid amplification technique and, occasionally, Genotype.
His most cited work include:
- Rapid molecular detection of tuberculosis and rifampin resistance. (1602 citations)
- Transmission of Tuberculosis in New York City. An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods (738 citations)
- A detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria. (738 citations)
What are the main themes of his work throughout his whole career to date?
David Alland mostly deals with Mycobacterium tuberculosis, Tuberculosis, Drug resistance, Microbiology and Genetics.
His Mycobacterium tuberculosis research is multidisciplinary, incorporating perspectives in Antibacterial agent, Rifampicin, Virology, Gene and Isoniazid.
His biological study spans a wide range of topics, including Multiple drug resistance and Ethambutol.
The study incorporates disciplines such as Internal medicine, In vitro and Molecular epidemiology in addition to Tuberculosis.
His study in Drug resistance is interdisciplinary in nature, drawing from both Dihydrofolate reductase, Demographic data, Gerontology and Genotype.
His Microbiology research integrates issues from Mycobacterium bovis, Amplicon, Sepsis and Enzyme.
He most often published in these fields:
- Mycobacterium tuberculosis (62.30%)
- Tuberculosis (36.07%)
- Drug resistance (31.15%)
What were the highlights of his more recent work (between 2011-2018)?
- Mycobacterium tuberculosis (62.30%)
- Molecular biology (21.31%)
- Sanger sequencing (6.56%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Mycobacterium tuberculosis, Molecular biology, Sanger sequencing, Gene and Drug resistance.
Mycobacterium tuberculosis is a subfield of Tuberculosis that David Alland studies.
In his research, Bacteremia and Sputum culture is intimately related to Internal medicine, which falls under the overarching field of Tuberculosis.
His studies deal with areas such as Chromatin and Peptide sequence as well as Molecular biology.
His Gene study integrates concerns from other disciplines, such as Proteases, Biophysics, DNA and Trypsin.
While the research belongs to areas of Drug resistance, David Alland spends his time largely on the problem of Kanamycin, intersecting his research to questions surrounding Sequence analysis.
Between 2011 and 2018, his most popular works were:
- Better tests, better care: improved diagnostics for infectious diseases. (335 citations)
- SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis (315 citations)
- Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study (255 citations)
In his most recent research, the most cited papers focused on:
Mycobacterium tuberculosis, Drug resistance, Tuberculosis, Prospective cohort study and Internal medicine are his primary areas of study.
The Mycolic acid research he does as part of his general Mycobacterium tuberculosis study is frequently linked to other disciplines of science, such as Transmembrane protein, therefore creating a link between diverse domains of science.
The concepts of his Drug resistance study are interwoven with issues in Medical microbiology, Sputum, Medical history and History of tuberculosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
